DFX Intelligence
Biospring Partners 2, LP
As of · the latest observation of this vehicle; each figure below carries its own filing date
Newly closedClosed to new capitalADV: Venture Capital Fund
As of · the latest observation of this vehicle; each figure below carries its own filing date
Nothing material in the last 365 days. Last change: 1 Jul 2025, Latest Form D filed on 1 Jul 2025: $10M sold of $10M offered, 3 investors. A Form D amount is what was sold at the filing, never a final close.
Drawing the relationship network…
Amounts, each with its basis
- Vintage
- 2025basis: form d first sale
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $10.0Mwhat may be sold, not what was raised; file 021-550423, sworn by the adviser or filed under this vehicle
- Form D sold
- $10.0Mas of the filing of Jul 1, 2025, 3 investors
- First sale
- Jun 16, 2025
- Reported GAV
- $26.6Mon the Form ADV filed Mar 27, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 4
- Reported on ADV
- unknown
Fundraising evidenceWhat counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Closed to new capital
Form D filed or amended 2025-07-01: the stated $10.0M offering reported fully sold (fr-1)
evidence dated Jul 1, 2025.
LifecycleNewly closed
first sale within 24 months; Form D sold out or quiet
first sale: Jun 16, 2025vintage year: 2025adv gav as of: Mar 27, 2026vintage basis: Form d first saleform d sold: $10.0Mform d offering: $10.0Mform d latest filed at: Jul 1, 2025
The fund's own reporting through time
1 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Venture Capital Fund | $26.6M | 4 | $2.0M | 0% |
Principals and agents
1 principal on Form D, 0 placement agents
- Michelle Detwiler Director/Executive Officer
Service providers
3 named on Form ADV Schedule D and Form D
- AuditorBDO · CHICAGO, Illinois, United StatesForm ADV filed Mar 27, 2026 reports.adviserinfo.sec.gov
- AdministratorADURO ADVISORS, LLC · DENVER, Colorado, United StatesForm ADV filed Mar 27, 2026 reports.adviserinfo.sec.gov
- CustodianJPMorgan · NEW YORK, New York, United StatesForm ADV filed Mar 27, 2026 reports.adviserinfo.sec.gov
Limited partners and their reported performanceWhose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Known LPs and allocatorsWhat these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.
0 relationships, public pensions and the allocator graph, each counted once
No allocator names this vehicle in a public disclosure DFX holds: pension reports, foundation 990-PF returns or endowment disclosures.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
- Mar 27, 2026Biospring Partners 2, LP first reported on Form ADV by Biospring Management, LLC (Venture Capital Fund), GAV $26,581,924Fund first reported on Form ADV Inference Form ADV
- Jul 1, 2025Biospring Partners 2, LP filed Form D: $10,000,000 sold of $10,000,000, Venture Capital FundForm D filed Fact Form D
Evidence
16 observations
Every observation on this vehicle
- Entity type: Limited Partnership Jul 1, 2025 Fact Form D
- Form D fund type: Venture Capital Fund Jul 1, 2025 Fact Form D
- Form D industry group: Pooled Investment Fund Jul 1, 2025 Fact Form D
- Amendment: false Jul 1, 2025 Fact Form D
- Revenue range (Form D): Decline to Disclose Jul 1, 2025 Fact Form D
- Incorporated: withinFiveYears Jul 1, 2025 Fact Form D
- Jurisdiction: Delaware Jul 1, 2025 Fact Form D
- Amount sold (Form D): $10.0M Jul 1, 2025 Fact Form D
- Offering amount (Form D): $10.0M Jul 1, 2025 Fact Form D
- Exemptions: 3C.7, 06b, 3C Jul 1, 2025 Fact Form D
- First sale: 2025-06-16 Jul 1, 2025 Fact Form D
- Investors (Form D): 3 Jul 1, 2025 Fact Form D
- Minimum investment (Form D): 2,000,000 Jul 1, 2025 Fact Form D
- Securities offered: Equity, pooled Jul 1, 2025 Fact Form D
- Office address: Jul 1, 2025 Fact Form D
- Year of incorporation: 2025 Jul 1, 2025 Fact Form D
Relationships across DFX
on 1 other DFX graph
Across the graphs
Biospring Partners 2, LP is the same institution as 1 record in RIA and Wealth.
RIA and Wealth1
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
2 dated events on the change ledger, latest event first
- Fund first reported on ADV2026-03-27source on record
- Form D filed2025-07-01source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.